?? MyCellHub Q4 2024 Newsletter: Updates and Milestones

?? MyCellHub Q4 2024 Newsletter: Updates and Milestones

As 2024 comes to a close, we’re grateful to reflect on key developments that have shaped MyCellHub’s journey this quater. From securing new investments to welcoming leadership talent and expanding into the U.S. market, here’s a look at what’s been happening:

?? New Investment Milestone

We’re excited to announce the successful completion of a new investment round, thanks to Thanks to the continuous support of its historical investors (LRM, Noshaq, The Faktory Fund and GEMMA FRISIUS - FONDS K.U.LEUVEN ) and the participation of its management, MyCellHub is happy to announce a successful new investment round!

We also welcome a U.S.-based investor, a major step toward our global growth ambitions.

Ief Leroy , chairman of the board, shared:

“This marks an important moment as we welcome our first U.S. investor and introduce our flagship customer to this market.”

?? Achieving ISO27001 Certification

We’re thrilled to announce that MyCellHub is now ISO 27001 certified! ?

This certification is the global ?? gold standard for information security, demonstrating our commitment to safeguarding ?? our clients’ and partners’ data. Achieving this milestone underscores our dedication to following top practices and building even greater trust ?? with everyone we work with.

?? Expanding into the U.S. with Our New Partner: HeartWorks

We’re excited to announce HeartWorks as our first U.S. customer! A leader in regenerative medicine, HeartWorks is driving innovation in clinical trials, and we’re honored to support their digital transformation efforts.

This partnership is an important milestone, helping us bring MyCellHub’s digital solutions to life sciences organizations across the globe.

Thank You from the MyCellHub Team!

#Investment #Growth #SaaS #MyCellHub #LifeSciences #USExpansion